DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 3Dr. Reddy's Laboratories
02 1Olpha
03 3Acino Pharma
04 3Assia Chemical Industries Ltd
05 3Azurity Pharma
06 5Exelixis
07 3Intas Pharmaceuticals
08 35Ipsen
09 2MSN Laboratories
10 3Pinnacle Life Science
01 3Antic-calc Tablet, Film Coated
02 2CAPSULE;ORAL
03 4Capsule
04 1Capsule, hard
05 3FCT
06 12Film Coated Tablet
07 1Hard Capsule
08 3Oral Solid Dosage Form
09 5TABLET
10 3TABLET; ORAL
11 6TABLET;ORAL
12 4Tablet
13 14Blank
01 3Allowed
02 5Approved
03 6Authorized
04 1Dossier Readiness: Q1 2026
05 3Lead Market Dossiers- Under Development
06 3Originator
07 3Prescription
08 5RX
09 32Blank
01 6CABOMETYX
02 1CABOMETYX 20 MG
03 1CABOMETYX 40 MG
04 1CABOMETYX 60 MG
05 5CABOZANTINIB
06 2COMETRIQ
07 24Cabometyx
08 3Cabozantinib
09 8Cometriq
10 3RESNIBEN
11 7Blank
01 12Australia
02 3Canada
03 9India
04 1Latvia
05 6Norway
06 3South Africa
07 6Spain
08 5Sweden
09 3Switzerland
10 13USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 20MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Olpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
Regulatory Info : Dossier Readiness: Q1 2026
Registration Country : Latvia
Brand Name :
Dosage Form : Tablet
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Readiness: Q1 2026
Registration Country : Latvia
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 40MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 60MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Regulatory Info :
Registration Country : USA
Brand Name : CABOZANTINIB
Dosage Form : TABLET;ORAL
Dosage Strength : 20MG
Packaging :
Approval Date :
Application Number : 215942
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : CABOZANTINIB
Dosage Form : TABLET;ORAL
Dosage Strength : 40MG
Packaging :
Approval Date :
Application Number : 215942
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : CABOZANTINIB
Dosage Form : TABLET;ORAL
Dosage Strength : 60MG
Packaging :
Approval Date :
Application Number : 215942
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : RESNIBEN
Dosage Form : TABLET; ORAL
Dosage Strength : 13MG
Packaging :
Approval Date :
Application Number : 220258
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : RESNIBEN
Dosage Form : TABLET; ORAL
Dosage Strength : 26MG
Packaging :
Approval Date :
Application Number : 220258
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : RESNIBEN
Dosage Form : TABLET; ORAL
Dosage Strength : 39MG
Packaging :
Approval Date :
Application Number : 220258
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : COMETRIQ
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 20MG BASE
Packaging :
Approval Date : 2012-11-29
Application Number : 203756
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : COMETRIQ
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 80MG BASE
Packaging :
Approval Date : 2012-11-29
Application Number : 203756
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : CABOMETYX
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 20MG BASE
Packaging :
Approval Date : 2016-04-25
Application Number : 208692
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : CABOMETYX
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 40MG BASE
Packaging :
Approval Date : 2016-04-25
Application Number : 208692
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : CABOMETYX
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 60MG BASE
Packaging :
Approval Date : 2016-04-25
Application Number : 208692
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Norway
Brand Name : Cabometyx
Dosage Form : Antic-calc Tablet, Film Coated
Dosage Strength : 20 mg
Packaging : Bottle
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Cabometyx
Dosage Form : Antic-calc Tablet, Film Coated
Dosage Strength : 40 mg
Packaging : Bottle
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Cabometyx
Dosage Form : Antic-calc Tablet, Film Coated
Dosage Strength : 60 mg
Packaging : Bottle
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : USA
Brand Name : CABOZANTINIB
Dosage Form : TABLET
Dosage Strength : 40MG
Packaging :
Approval Date :
Application Number : 213878
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : CABOZANTINIB
Dosage Form : TABLET
Dosage Strength : 20MG
Packaging :
Approval Date :
Application Number : 213878
Regulatory Info :
Registration Country : USA
